Ocean Outdoor appoints Thomas Ebeling to its Board as Independent Director

– UK, London – Ocean Outdoor Limited (LON:OOUT) today announced that Thomas Ebeling has joined the Board of the Company as independent non-executive Director with immediate effect.

Mr Ebeling served as CEO of ProSiebenSat.1 Media SE from 2009 until 2018. He has been a member of the supervisory board of Bayer AG since 2012, and in 2017 joined the boards of GfK SE, Cullinan Oncology, LLC and Clear VAT AG. Between 1997 and 2008, Mr Ebeling held various positions within the Novartis group, including chief executive officer of Novartis Consumer Health at Novartis AG from October 2007 to October 2008, and chief executive officer of the Pharmaceuticals Division of Novartis AG from 2000 to 2007.

Tom Goddard, Chairman, commented: “We are delighted to welcome Thomas to the board. In recent discussions with him I was reminded just how impressive his grasp of the current media landscape is, which will be of great benefit to Ocean.”

About Ocean Outdoor

Ocean Outdoor is the leading operator of premium digital out-of-home advertising in the United Kingdom with a portfolio of large format digital screens, banner and super premium landmark advertising sites.

Ocean Outdoor operates the most iconic outdoor sites in London, Birmingham, Manchester, Liverpool, Newcastle, Nottingham, Leeds and Scotland. They include Landsec’s Piccadilly Lights, Britain’s largest advertising site the BFI IMAX; Two Towers East and Two Towers Manchester; and the Liverpool Media Wall, the UK’s second biggest full-motion advertising site. Ocean also holds exclusive exterior DOOH rights for the most premium urban shopping malls in Europe; Westfield London and Westfield Stratford.

For more information : http://www.oceanoutdoor.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.